Stock comparison
Novo Nordisk A/S
NVO$208.92BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.05BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
NVO 07 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
NVO0wins
7winsSANOFICONR.BO
65C
B78
62C
A89
75B
B83
59D
B77
55D
A91
75B
A86
72B
A85
Side-by-side metrics
| Metric | NVO | SANOFICONR.BO |
|---|---|---|
| Market cap | Winner: $208.92B | $104.05B |
| P/E (TTM) | Winner: 12.9x | 44.0x |
| EV/EBIT | Winner: 10.6x | 31.7x |
| ROIC (TTM) | 33.58% | 59.15% Winner |
| Gross margin | Winner: 80.98% | 68.13% |
| Net margin | Winner: 33.14% | 27.35% |
| Revenue CAGR 5y | 20.43% | 27.01% Winner |
| EPS CAGR 5y | Winner: 23.53% | 20.67% |
| Debt / Equity | 0.7x | 0.1x Winner |
| Dividend yield | 3.99% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
NVO leads on
- P/E (TTM)12.9xvs 44.0x+71%
- EV/EBIT10.6xvs 31.7x+67%
- Market cap$208.92Bvs $104.05B+50%
- Net margin33.14%vs 27.35%+17%
SANOFICONR.BO leads on
- Debt / Equity0.1xvs 0.7x+90%
- ROIC (TTM)59.15%vs 33.58%+43%
- Revenue CAGR 5y27.01%vs 20.43%+24%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.